ALAMEDA, Calif. – January 15, 2015 – LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect, a powerful, yet easy-to-use application for prioritizing gene variants resulting from next generation sequencing (“NGS”) experiments. VarElect rapidly prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in identifying the roles of genes and their variants in biological processes, health, and disease.
Access VarElect here: http://varelect.genecards.org. Continue reading LifeMap Sciences, a Subsidiary of BioTime, Announces Release of VarElect, the Next Generation Sequencing Phenotyper